Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field
- 15 June 2024
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 198, 110384
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- University of California, San Francisco
- NIH Division of Loan Repayment (L40 CA264321)
This publication has 38 references indexed in Scilit:
- Late effects in survivors of high‐risk neuroblastoma following stem cell transplant with and without total body irradiationPediatric Blood & Cancer, 2021
- A safety and feasibility trial of 131I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group studyPediatric Blood & Cancer, 2021
- Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk NeuroblastomaJAMA, 2019
- Efficacy of proton therapy in children with high‐risk and locally recurrent neuroblastomaPediatric Blood & Cancer, 2019
- Role of the extent of prophylactic regional lymph node radiotherapy on survival in high‐risk neuroblastoma: A report from the COG A3973 studyPediatric Blood & Cancer, 2019
- Neuroblastoma: clinical and biological approach to risk stratification and treatmentCell and tissue research, 2018
- Dose‐escalation is needed for gross disease in high‐risk neuroblastomaPediatric Blood & Cancer, 2018
- Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: A Pediatric Oncology Group study: A Report from the Children's Oncology GroupPediatric Blood & Cancer, 2012
- Intensified External-Beam Radiation Therapy Improves the Outcome of Stage 4 Neuroblastoma in Children > 1 Year with Residual Local DiseaseStrahlentherapie und Onkologie, 2006
- Long-term results of therapy for stage C neuroblastomaJournal of Surgical Oncology, 1996